Company news
Shield Therapeutics PLC news in 2018
Shield Therapeutics PLC's news releases, calls and decks from 2018, newest first.
US New Drug Application PDUFA date for Feraccru
December 13, 2018
UK launch of Feraccru® by Norgine
December 5, 2018
New Drug Application for Feraccru®
December 3, 2018
Notification Of Major Holdings
October 1, 2018
Licence for the commercialisation of Feraccru
September 19, 2018
AEGIS-H2H Completion of Recruitment
September 13, 2018
Business Update
July 23, 2018
Holdings in Company
July 9, 2018
Data from real-world clinical use of Feraccru
June 28, 2018
Positive top-line results from AEGIS-PAED PK study
June 14, 2018
2017 Annual Report and 2018 AGM Notice
June 5, 2018
Preliminary Results for the Year Ended 31 Dec 17
April 11, 2018
Results of Pre-Submission Meeting with FDA
April 6, 2018
Broadening of Feraccru indication
March 27, 2018
Update on the AEGIS-CKD study
March 16, 2018
Receives CHMP positive opinion on Feraccru®
February 23, 2018
Business and Trading Update
February 22, 2018
Top-line results from Feraccru Phase III study
February 5, 2018